Prolia

Prolia Drug Interactions

denosumab

Manufacturer:

Amgen

Distributor:

Zuellig
Full Prescribing Info
Drug Interactions
Denosumab (Prolia) (60 mg subcutaneously) did not affect the pharmacokinetics of midazolam, which is metabolized by cytochrome P450 3A4 (CYP3A4), indicating that it should not affect the pharmacokinetics of drugs metabolized by this enzyme (see Pharmacology: Pharmacokinetics under Actions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in